SANUWAVE Health Inc
OTC:SNWV
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
SANUWAVE Health Inc
OTC:SNWV
|
219.2m USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
190.2B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
174.8B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
136.4B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
131.4B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
114.3B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
58.9B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.7B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.3B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
39.3B USD |
Loading...
|
Market Distribution
| Min | -4 418 600% |
| 30th Percentile | -9.6% |
| Median | 3.1% |
| 70th Percentile | 11.3% |
| Max | 1 135 400% |
Other Profitability Ratios
SANUWAVE Health Inc
Glance View
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. The company is headquartered in Suwanee, Georgia and currently employs 43 full-time employees. The company went IPO on 2008-11-07. The firm's is focused on regenerative medicine utilizing noninvasive, acoustic shock waves to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body’s normal healing processes and regeneration. The firm's lead regenerative product in the United States is the dermaPACE device, used for treating diabetic foot ulcers. The company intends to apply its Pulsed Acoustic Cellular Expression (PACE) technology in wound healing, orthopedic, plastic/cosmetic and cardiac conditions.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for SANUWAVE Health Inc is -17.1%, which is above its 3-year median of -97.3%.
Over the last 3 years, SANUWAVE Health Inc’s Net Margin has increased from -86% to -17.1%. During this period, it reached a low of -276.1% on Sep 30, 2023 and a high of -1.3% on Sep 30, 2024.
